These results show that mJX-594 effectively infected and destroyed cancer cells, and released cancer antigens in an immunogenic manner, thus efficiently activating and recruiting cancer antigen-specific CD8+ T cells into the tumor tissue. This evidence concerns the gene CD8A and cancer.